Highlights and Quick Summary
- Total non-current liabilities for the quarter ending June 30, 2023 was $1.73 Million (a 87.51% increase compared to previous quarter)
- Year-over-year quarterly Total non-current liabilities decreased by -91.48%
- Annual Total non-current liabilities for 2022 was $1.11 Million (a -95.4% decrease from previous year)
- Annual Total non-current liabilities for 2021 was $24.2 Million (a -2.7% decrease from previous year)
- Annual Total non-current liabilities for 2020 was $24.8 Million (a -5.94% decrease from previous year)
Visit stockrow.com/DRRX
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Total non-current liabilities of DURECT Corporation
Most recent Total non-current liabilitiesof DRRX including historical data for past 10 years.Interactive Chart of Total non-current liabilities of DURECT Corporation
DURECT Corporation Total non-current liabilities for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | $1.73 | $0.92 | – | – | – |
| 2022 | $1.11 | $20.26 | $22.68 | $23.9 | $1.11 |
| 2021 | $24.15 | $24.37 | $24.59 | $22.63 | $24.15 |
| 2020 | $24.82 | $25.9 | $26.07 | $36.3 | $24.82 |
| 2019 | $26.39 | $25.56 | $26.51 | $27.64 | $26.39 |
| 2018 | $22.34 | $12.64 | $15.28 | $17.99 | $22.34 |
| 2017 | $15.8 | $17.93 | $24.27 | $22.35 | $15.8 |
| 2016 | $3.42 | $23.5 | $23.64 | $22.68 | $3.42 |
| 2015 | $24.44 | $24.37 | $24.61 | $22.79 | $24.44 |
| 2014 | $24.6 | $22.68 | $22.6 | $2.84 | $24.6 |
| 2013 | $2.91 | $3.0 | $2.2 | $2.28 | $2.91 |
| 2012 | $2.68 | $2.22 | – | – | $2.68 |
Business Profile of DURECT Corporation
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic